Department of Cardiology 2142, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Denmark.
Department of Cardiology 2142, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Denmark.
Resuscitation. 2015 Apr;89:36-42. doi: 10.1016/j.resuscitation.2014.12.031. Epub 2015 Jan 22.
Bradycardia is a common finding in patients undergoing therapeutic hypothermia (TH) following out-of-hospital cardiac arrest (OHCA), presumably as a normal physiological response to low body temperature. We hypothesized that a normal physiological response with sinus bradycardia (SB) indicates less neurological damage and therefore would be associated with lower mortality.
We studied 234 consecutive comatose survivors of OHCA with presumed cardiac etiology and shockable primary rhythm, who underwent a full 24-h TH-protocol (33°C) at a tertiary heart center (years: 2004-2010). Primary endpoint was 180-day mortality; secondary endpoint was favorable neurological outcome (180-day cerebral performance category: 1-2).
SB, defined as sinus rhythm <50 beats per minute during TH, was present in 115 (49%) patients. Baseline characteristics including sex, witnessed arrest, bystander cardiopulmonary resuscitation and time to return of spontaneous circulation were not different between SB- and no-SB patients. However, SB-patients were younger, 57±14 vs. 63±14 years, p<0.001 and less frequently had known heart failure (7% vs. 20%, p<0.01). Patients experiencing SB during the hypothermia phase of TH had a 17% 180-day mortality rate compared to 38% in no-SB patients (p<0.001), corresponding to a 180-day hazard ratio (HRadjusted=0.45 (0.23-0.88, p=0.02)) in the multivariable analysis. Similarly, SB during hypothermia was directly associated with lower odds of unfavorable neurological outcome (ORunadjusted=0.42 (0.23-0.75, p<0.01).
Sinus bradycardia during therapeutic hypothermia is independently associated with a lower 180-day mortality rate and may thus be a novel, early marker of favorable outcome in comatose survivors of OHCA.
在院外心脏骤停(OHCA)后接受治疗性低温(TH)的患者中,心动过缓是一种常见的发现,推测是低温对身体的正常生理反应。我们假设窦性心动过缓(SB)是一种正常的生理反应,表明神经损伤较小,因此与死亡率较低有关。
我们研究了 234 例连续昏迷的 OHCA 幸存者,这些幸存者的病因被认为是心脏原因,且初始节律为可除颤性节律,并在一个三级心脏中心接受了完整的 24 小时 TH 方案(33°C)(年份:2004-2010 年)。主要终点为 180 天死亡率;次要终点为良好的神经功能结局(180 天脑功能分类:1-2 级)。
SB 定义为 TH 期间窦性节律<50 次/分钟,存在于 115 例(49%)患者中。SB 患者与非 SB 患者的基线特征,包括性别、目击性骤停、旁观者心肺复苏和自主循环恢复时间均无差异。然而,SB 患者更年轻,57±14 岁 vs. 63±14 岁,p<0.001,且较少患有已知的心力衰竭(7% vs. 20%,p<0.01)。在 TH 低温阶段经历 SB 的患者 180 天死亡率为 17%,而非 SB 患者为 38%(p<0.001),多变量分析中 180 天的危险比(HRadjusted=0.45(0.23-0.88,p=0.02))。同样,SB 在低温时与神经功能不良结局的可能性降低直接相关(ORunadjusted=0.42(0.23-0.75,p<0.01))。
TH 期间的窦性心动过缓与 180 天死亡率较低独立相关,因此可能是 OHCA 昏迷幸存者良好预后的一种新的早期标志物。